nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Animal models of arthritis in NOS2-deficient mice
|
van den Berg, W.B. |
|
1999 |
7 |
4 |
p. 413-415 3 p. |
artikel |
2 |
Clinical trials design: structure modifying agents for osteoarthritis. Future guidelines: areas for development
|
Bellamy, N. |
|
1999 |
7 |
4 |
p. 424-426 3 p. |
artikel |
3 |
COX-2 in synovial tissues
|
Crofford, L.J. |
|
1999 |
7 |
4 |
p. 406-408 3 p. |
artikel |
4 |
Foreword
|
|
|
1999 |
7 |
4 |
p. 359-360 2 p. |
artikel |
5 |
Heritable osteoarthritis. Diagnosis and possible modes of cell and gene therapy
|
Prockop, D.J. |
|
1999 |
7 |
4 |
p. 364-366 3 p. |
artikel |
6 |
Human chondrocyte culture models for studying cyclooxygenase expression and prostaglandin regulation of collagen gene expression
|
Goldring, M.B. |
|
1999 |
7 |
4 |
p. 386-388 3 p. |
artikel |
7 |
Interactions between the inducible cyclooxygenase (COX-2) and nitric oxide synthase (iNOS) pathways: implications for therapeutic intervention in osteoarthritis
|
Needleman, P. |
|
1999 |
7 |
4 |
p. 367-370 4 p. |
artikel |
8 |
Mechanisms of chondrocyte apoptosis
|
Lotz, M. |
|
1999 |
7 |
4 |
p. 389-391 3 p. |
artikel |
9 |
Modulation of IL-1 effects on cartilage by NO synthase inhibitors: pharmacological studies in rats
|
Jouzeau, J.-Y |
|
1999 |
7 |
4 |
p. 382-385 4 p. |
artikel |
10 |
Nitric oxide alters chondrocyte function by disrupting cytoskeletal signaling complexes
|
Clancy, R. |
|
1999 |
7 |
4 |
p. 399-400 2 p. |
artikel |
11 |
Nitric oxide in osteoarthritis
|
Studer, R. |
|
1999 |
7 |
4 |
p. 377-379 3 p. |
artikel |
12 |
Pathophysiology of osteoarthritis
|
Martel-Pelletier, J. |
|
1999 |
7 |
4 |
p. 371-373 3 p. |
artikel |
13 |
Phosphocitrate blocks nitric oxide-induced calcification of cartilage and chondrocyte-derived apoptotic bodies
|
Cheung, H.S. |
|
1999 |
7 |
4 |
p. 409-412 4 p. |
artikel |
14 |
Prostaglandins and bone: physiology and pathophysiology
|
Raisz, L.G. |
|
1999 |
7 |
4 |
p. 419-421 3 p. |
artikel |
15 |
Radiographic assessment. Introduction: existing methodology
|
Rovati, L.C. |
|
1999 |
7 |
4 |
p. 427-429 3 p. |
artikel |
16 |
Radiographic assessment of hip and knee osteoarthritis. Recommendations: recommended guidelines
|
Vignon, E. |
|
1999 |
7 |
4 |
p. 434-436 3 p. |
artikel |
17 |
Radiographic assessment of osteoarthritis: comparison between existing methodologies
|
Buckland-Wright, |
|
1999 |
7 |
4 |
p. 430-433 4 p. |
artikel |
18 |
Reduction in the structural changes of experimental osteoarthritis by a nitric oxide inhibitor
|
Pelletier, J.-P. |
|
1999 |
7 |
4 |
p. 416-418 3 p. |
artikel |
19 |
Regulation of tumor necrosis factor-α and tumor necrosis factor converting enzyme in human osteoarthritis
|
Amin, A.R. |
|
1999 |
7 |
4 |
p. 392-394 3 p. |
artikel |
20 |
Role of nitric oxide in the angiogenesis of avascular tissue
|
Ziche, M. |
|
1999 |
7 |
4 |
p. 403-405 3 p. |
artikel |
21 |
Sites of action for future therapy: an adenosine-dependent mechanism by which aspirin retains its antiinflammatory activity in cyclooxygenase-2 and NFκB knockout mice
|
Cronstein, B.N. |
|
1999 |
7 |
4 |
p. 361-363 3 p. |
artikel |
22 |
Suppression of tumor necrosis factor (TNF-α) gene expression by prostaglandin E2. Role of early growth response protein-1 (Egr-1)
|
Di Battista, J.A. |
|
1999 |
7 |
4 |
p. 395-398 4 p. |
artikel |
23 |
T-cell mediated inflammatory pathway in osteoarthritis
|
Nakamura, H |
|
1999 |
7 |
4 |
p. 401-402 2 p. |
artikel |
24 |
The influence of tissue cross-talking on OA progression: role of nonsteroidal antiinflammatory drugs
|
Pelletier, J.P. |
|
1999 |
7 |
4 |
p. 374-376 3 p. |
artikel |
25 |
The role of COX-2 produced by cartilage in arthritis
|
Abramson, S.B. |
|
1999 |
7 |
4 |
p. 380-381 2 p. |
artikel |
26 |
The role of prostaglandins and nitric oxide in the response of bone to mechanical forces
|
Chambers, T.J. |
|
1999 |
7 |
4 |
p. 422-423 2 p. |
artikel |